Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.

Goadsby PJ, Friedman DI, Holle-Lee D, Demarquay G, Ashina S, Sakai F, Neel B, Gandhi P, Dabruzzo B, Smith JH, Liu Y, Trugman JM.

Open source

DOI: 10.1212/wnl.0000000000209584
Published: 2024-06-26
Container: Neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1212/wnl.0000000000209584,
  title = {Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.},
  author = {Goadsby PJ and  Friedman DI and  Holle-Lee D and  Demarquay G and  Ashina S and  Sakai F and  Neel B and  Gandhi P and  Dabruzzo B and  Smith JH and  Liu Y and  Trugman JM.},
  year = {2024},
  journal = {Neurology},
  doi = {10.1212/wnl.0000000000209584},
  url = {https://doi.org/10.1212/wnl.0000000000209584}
}

RIS

TY  - JOUR
TI  - Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
AU  - Goadsby PJ
AU  -  Friedman DI
AU  -  Holle-Lee D
AU  -  Demarquay G
AU  -  Ashina S
AU  -  Sakai F
AU  -  Neel B
AU  -  Gandhi P
AU  -  Dabruzzo B
AU  -  Smith JH
AU  -  Liu Y
AU  -  Trugman JM.
PY  - 2024
JO  - Neurology
DO  - 10.1212/wnl.0000000000209584
UR  - https://doi.org/10.1212/wnl.0000000000209584
ER  -

APA

PJ, G., DI, F., D, H., G, D., S, A., F, S., B, N., P, G., B, D., JH, S., Y, L., & JM., T. (2024). Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.. Neurology. https://doi.org/10.1212/wnl.0000000000209584

Source records

europe-pmc · retrieved 2026-09-27T14:08:28.646Z
hal · retrieved 2026-09-27T14:08:28.596Z